Volumina Medical won the Seed Night prize for its injectable implant.   The event organized by the EPFL, Venturelab and...

The 5th edition of the Arkathon – Hacking Health Valais took place from 12 to 14 April in Sion.  ...

SOPHiA GENETICS’ Solid Tumor Solution (STS) receives the CE-IVD marking   Western Switzerland based global leader in Data-Driven Medicine, SOPHiA...

EspeRare annonce un partenariat avec Dermelix Biotherapeutics pour DMX-101, et le lancement de la phase pivotale pour une thérapie in...

Two EPFL professors received ERC Advanced Grants for their research in cell science and immunotherapy   Professors Pierre Gönczy and...

Is Swiss Venture Capital now rising too fast?   A few years back, Swiss pension funds remained cautious when it...

Scientists from EPFL’s BionanoPhotonic Systems (BIOS) Laboratory have created a powerful sensor which will be able to support at-home disease identification.  ...

Prof Pantaleo’s work published as part of the “Milestones” edition of Nature.   In this edition, Nature identifies the 21...

The EPFL’s Blue Brain Project has identified how to mathematically determine a neuron type classification based on the neuron’s shape....

UNIGE and UNIL scientists have discovered that clofazimine can be used to reduce tumors in the case of “triple negative” breast...

Imitating the complexity of cellular function while having access to a simpler system which can be mathematically altered.   Scientists...

Aktiia’s cuffless blood pressure measurement device only needs calibrating every two months   Aktiia’s founders have worked for the past...